Supernus Pharmaceuticals reported $165.5M in Sales Revenues for its fiscal quarter ending in June of 2025.


Sales Change Date
Abbott USD 11.42B 1.06B Jun/2025
ANI Pharmaceuticals USD 211.37M 14.27M Jun/2025
Aurora Cannabis CAD 98.02M 9.82M Jun/2025
Bristol-Myers Squibb USD 12.27B 1.07B Jun/2025
Canopy Growth CAD 72.13M 2.63M Jun/2025
Corcept Therapeutics USD 194.4M 37.2M Jun/2025
Eisai JPY 202.65B 14.41B Jun/2025
Eli Lilly USD 15.56B 2.83B Jun/2025
Novo Nordisk 76.86B 1.23B Jun/2025
Pacira USD 181.1M 12.18M Jun/2025
Perrigo USD 1.06B 20M Jun/2025
Pfizer USD 14.7B 980M Jun/2025
Supernus Pharmaceuticals USD 165.5M 15.7M Jun/2025
United Therapeutics USD 798.6M 4.2M Jun/2025
Xeris Pharmaceuticals USD 71.54M 11.44M Jun/2025